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N-acetyltransferase, an enzyme involved in the metabolic inactivation of 
drugs like isoniazide, some sulfonamides and others is well-known to he under 
polymorphic genetic control. The acetylation phenotype of the patients may 
serve as an important guide in foretelling the therapeutic efficacy or tolerahility 
of a particular drug. In the present study we investigated the distribution of the 
acetylaiion phenotypes in a group of100 healthy volunteers of both sexes using 
sulfadimidine as a substrate. The distribution was found to follow a bimodal 
pattern, as aspected, with a slight predominance of the "slow" acetylators - in 
5H % of the cases, a finding similar to literature data from neighbouring and 
other European countries. In the men's group the distribution was 
approximately the same as that in the whole group whilst in the women's one the 
"rapid" inactivators prevailed. This work represents the first modest attempt in 
Bulgaria for phenotyping the population according to the individual acetylaiion 
status. 
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I N T R O D U C T I O N 
The interest in the genetically 
polymorphous biotransformation of drugs, 
and in particular in the polymorphism of 
drug acetylation and oxidation, is 
constantly rising ( 1 - 3 , 5. 6. 9. 13. 14). 
This interest is determined by the causal 
relation between polymorphous drug 
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metabolism and some initially puzzling 
variations in the therapeutic effects of 
different daigs. This polymorphism is also 
related to the different individuals' 
susceptibility in a human population to 
drugs' adverse effects, as well as to the risk 
of development of some diseases, including 
malignancies (2. 7. 13. 14). 
According to data from the literature 
available, the enzyme system responsible 
for the polymorphic acetylation of daigs 
like isoniazide. procainamide, depressan. 
some sulfonamides (e. g., sulfadimidine), 
as well as carcinogenic aromatic amines, is 
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nonmicrosomic, npninducible N-
tyltransferase (2, 5, 6). The low hepatic 
cetyltransferase activity is controlled by a 
single recessive gene. The ratio of 
"rapid'V'slow" acetylators varies 
remarkably in different ethnic and/or 
geographic origin populations. "Slow" 
acetylators are rarely to be met (5-10 per 
cent) amongst mongoloid population of the 
Far East (Eskimos, Japanese. Chinese) and 
are widely represented (80-90 per cent) in 
Egyptians or Moroccans, while in the rest 
of the world their incidence varies between 
these extremities (2, 4, 5, 11, 12, 14). 
The present study aims at two goals: 1. 
To determine the incidence rate of the 
acetylator phenotypes in a group of 
volunteers from the north-east region of 
Bulgaria using sulfadimidine as a 
substrate; 2. To compare the results with 
literature data on the same topic concerning 
дгореап and other populations. 
A T E R I A L AND M E T H O D S 
е investigation was carried out on 
I healthy volunteers - medical students 
both sexes (78 males and 22 females) 
unrelated to each other with an average age 
of 22 years. Participants in the study were 
asked not to consume alcohol and not to 
take any other medicines at least 48 hours 
before the experiment. The procedure of 
the trial was as followed (8, 10): 
A tablet of 500 mg sulfadimidine was 
given to every participant at 7 a. m. with a 
little of water on an empty stomach. Urine 
was collected for analysis at about 9 a. m. 
in bottles provided by the laboratory. It 
was diluted 1:100 with distilled water. Two 
tubes with diluted urine and hydrochloric 
id added were boiled for 1 hour in a 
water bath to produce hydrolysis of the 
acetylated sulfadimidine back to the free 
form. These two tubes were used for 
determination of the total sulfadimidine 
(free + acetylated). Other two tubes of the 
same content, but not boiled, were used to 
estimate the free sulfadimidine. The urine 
was treated with sodium nitrate, 
ammonium sulfate, and 
naphthylethylenediamine in a fixed 
schedule to yield a colour compound. The 
sulfadimidine concentration was then 
measured spectrophotometrically at 550 
nm. The percentage of sulfadimidine 
excreted in the acetylated form was given 
by: 
A % 'total ' free x l 0 0 
'free 
Individuals in which this percentage 
was higher than 70 were considered "rapid" 
acetylators but those with a percentage 
lower than 70 - "slow" acetylators (10). 
R E S U L T S 
The frequency distribution of these 
volunteers according to their acetylator 
phenotype shows a bimodal curve (Fig. 
l).This is considered an evidence for the 
present genetic control in the activity of the 
drug-metabolizing N-acetyltransferase. 
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Fig. 1. Frequency distribution histogram of the 
percentage acetylated sulfadimidine in urine of 
100 healthv unrelated volunteers 
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Fig. 2. Frequency distribution histogram of the Fig. 3. Frequency distribution histogram of the 
percentage acetylated sulfudimidine in urine of percentage acetyl ate dsulfadimidine of 22 
7S healthy male volunteers healthy female volunteers 
The "slow" acetylators slightly 
predominate representing 58 per cent of the 
whole group. From a genetical point of 
view they are homozygotes. This is 
probably the reason for the well-shaped 
"mode" in their grouping. 
A certain split in the curve of the group 
of "rapid" acetylators is to be noted. This 
fact could be explained by two ways: on 
the one hand, participants' number in the 
experiment is relatively small, and. on the 
other hand, the "rapid" acetylators are not a 
homogenous group in that they could be 
either homozygotes (RR) . or heterozygotes 
(Rr) thus some disturbances in the smooth 
line of the curve could be caused. 
The analysis of the frequency 
distribution of the acetylator phenotypes 
according to sex reveals that in men it 
coincides with that of the whole group (Fig. 
2). In women, however, a prevalence of the 
"rapid" acetylators is found out (Fig. 3) -
they represent 55 per cent of the cases 
versus 42 per cent in the whole group. 
DISCUSSION 
Our results are similar to literature data 
available concerning the frequency 
distribution of acetylator phenotypes in 
some population groups like those of India. 
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Finland. South Norway, the white 
population of the USA, Hispanic 
Americans, and Turks. In these groups 
slow acetylators are established in 
approximately the same percentage (2, 4, 
5, 11. etc.) as in our study. The picture of 
the Turkish population is of particular 
interest to us because of the close territorial 
relations to Bulgaria, although variations 
are reported according to the different 
subregions involved in the study (5). 
It is generally believed that the 
acetylation rate depends mainly on the race 
but not on the gender (5, 13). However, 
some evidence exists, according to which 
among female individuals in some species 
of experimental animals (rats) and in 
humans "rapid" acetylators are more 
commonly met (2, 15). A possibility is 
discussed that the expressiveness of the 
"rapid" gene may be under estrogen control 
or that testosteron can be the factor leading 
to "slowing" of the phenotype in males (2). 
However, the small number of our female 
contingent does not allow us to draw a 
definite conclusion about the observed 
difference. 
The age homogeneity of our group of 
volunteers prohibits us from discussing on 
the controversial question about the 
influence of the age on the acetylation 
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phenotype. According to certain authors (5, 
13), this factor does not exert any effects 
upon the frequency distribution while other 
investigators (12) report that among elderly 
people (e. g., Hungarians) the slow 
acetylators of sulfadimidine occur more 
often. 
C O N C L U S I O N 
We could conclude that as, to our 
knowledge, no data exist on the 
pharmacogenetics of the acetylation 
polymorphism in a Bulgarian population, 
our investigation may be considered the 
first modest attempt to fill in this blank 
space of our medico-biological science. 
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Pharmakogenetische Untersuchung des Azetylierungsphenotypen in 
der bulgarischen Bevolkcrung 
M. Zhelyazkowa, P. Borisowa, K . Marazowa, N. Temnyalov, L . Tzvetkov, V. 
Lozewa, S. Waltschewa, A. Beltschewa, D. Zhelyazkov 
Lehrstuhl fiir Pharmakologie, Mcdizinische University Varna 
Zusammenfassung: Es ist bekannt, dali die N-Azetyltransferase, die die 
Azetylierung von Isoniazid, einigen Sulfonamiden und anderen Arzneimitteln 
katalysiert, sich miter einer polymorphen genetischen Kontrolle befindet. Die 
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Fcststellung des Phenotypen der Kranken als "schnnelle" Azetylierer oder als 
"langsame" Azetylierer konnte zur Prognosiemng der therapeutischen 
Wirksamkeit und der Vertraglichkeit entsprechender Arzneimittel dienen. In der 
vorliegenden Arbeit wurde die Verteilung von 100 Probanden beider Geschlechter 
nach ihrem azetylierenden Phenotyp hinsichtlich des Sulfadimidins untersucht. 
Die Ergebnisse stellten eine gut ausgepragte bimodale Kurve dar. Der Prozentsatz 
der Langsamazetylierer war leicht uberwiegend - in 5X % der Falle. Diese Daten 
stimmten mit entsprechenden Angaben von benachbarten Regionen unseres 
Landes iiberein. Bei Mannern war die Verteilung mit dieser der ganzen Gruppe 
gleich. wahrend bei Frauen die Schnellazetylierer uberwiegend waren. Diese 
Arbeit stellt einen ersten Versuch fur eine pharmakogenetische Phenotypisierung 
der bulgarischen Bevolkerung nach ihrem azetylierenden Status dar.. 
Etude pharmacogenetique sur le phenotype acetylant chez la 
population bulgare 
M. Zheliazkova, P. Borisova, K . Marazova, N. Temnialov, L . Tsvetkov, V. 
Lozeva, S. Valtcheva, A. Beltcheva, D. Zheliazkov 
С ha ire de pharmacologic, Universite de medecine a Varna 
Resume: II est bien connu. que N-acetyltransferase - Penzyme qui est engagee 
dans l'acetylation des certains medicaments comme 1'isoniaside, quelque 
sulfonamides et bien autres, se trouve sous un controle genetique polymoфllique. 
La connaissance du phenotype acetylant des malades - "rapide" ou "lent", pourrait 
etre utilisee pour qu'on peut prevoir Tefficacite du traitement et la tolerance aux 
medicaments respectifs. Dans ce but on a etudie la distribution d'un groupe de 
volontaires - 100 personnes des deux sexes, d'apres leur phenotype acetylant en 
utilisant le substrat sulfadimidine. Les resultats forment line courbe bimodale bien 
marquee. Une predomination des acetylateurs "lents" - 5X %. etait observee, ce 
qui coincide avec des donnees similaires des regions voisines du pays. Chez les 
hommes la distribution est similaire de celle du groupe entier, tandis que chez les 
femmes les inactivateurs "rapides" predominent. Le travail presente est un 
premier essai en Bulgarie d'une phenotypisation phamiacogenetique de la 
population selon son statut acetylant. 
